Polyrizon Ltd. (PLRZ) vs Tvardi Therapeutics, Inc. (TVRD)
Over the past year, TVRD lagged PLRZ — -97.12% vs 41.36% annualized total return (price plus dividends).
A side-by-side comparison of Polyrizon Ltd. and Tvardi Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
Total return — PLRZ vs TVRD
growth of $100 · dividends reinvested · last 1yMetrics side by side
Did TVRD beat PLRZ?
Over the past year, TVRD lagged PLRZ — -97.12% vs 41.36% annualized total return (price plus dividends).
Total return (annualized)
| Metric | PLRZ | TVRD |
|---|---|---|
| Total return (1Y) | 41.36% | -97.12% |
PLRZ is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has TVRD beaten PLRZ?
- Over the past year, TVRD lagged PLRZ — -97.12% vs 41.36% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.